Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 277 No 7432 p761
23/30 December 2006

This article
Reprint   Photocopy

  Acrobat Reader


News summary


NPSA to change its focus as part of new patient safety strategy

DoH report: Safety first

The DoH’s report

Procedures designed to improve patient safety are to be overhauled next year, including a redesign of the National Patient Safety Agency's National Reporting and Learning System and of the NPSA itself. The recommendations come in “Safety first: a report for patients, clinicians and health care managers”, published by the Department of Health last week as part of a renewed national strategy for patient safety.

The report is the result of a review commissioned by the Chief Medical Officer for England to address issues raised in the National Audit Office report “A safer place for patients: learning to improve patient safety” (PJ, 12 November 2005, p597) as well as to look at the NHS approach to patient safety more widely.

The review found little evidence, despite the large volume of reports, that the NRLS is delivering high-quality, routinely available information on patterns, trends and underlying causes of harm to patients. It says that the system must be re-engineered to make it more effective. Near misses and a new category of “adverse events that could happen” should be reported and reports should be simplified. To promote rapif and effective learning, reports should be confidential but not anonymous. The new system will be relaunched in 2007.

The report also recommends that the role of the NPSA should be refocused on its core objective of collecting and analysing patient safety data to inform rapid patient safety learning, priority setting and co-ordinated activity across the NHS.

It advises that the NPSA should work in partnership with agencies that gather data, such as complaints, claims and coroners’ reports, to ensure that all deaths and serious harm associated with adverse events are identified.

To allow this to happen, the report recommends that a number of the NPSA’s current functions should be commissioned from other expert agencies. These functions include patient involvement, awareness raising, technical solution development and education. A pilot should be established to examine whether the National Institute for Health and Clinical Excellence could develop technical patient safety solutions.

Other recommendations

• All incident reports should be considered locally within 24 hours and the NPSA should be notified of any incidents involving serious patient harm or death within 36 hours

• Patient safety action teams, accountable to strategic health authorities, should work to support local NHS organisations and would decide which incidents should be investigated and at what level

• The NHS Institute for Innovation and Improvement should work with the medical Royal colleges to develop a patient safety curriculum, which should be widely implemented in undergraduate, postgraduate and continuing education

• A National Patient Safety Forum should be established to bring together key stakeholders and influence the development of the patient safety agenda

• The NHS should take steps to ensure that patient safety is embedded as a core principle that underpins the next round of national priorities, which will be established from 2008

Back to Top


©The Pharmaceutical Journal